Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 117,835 | 118,719 | 491,683 | 446,966 | 499,450 |
| Marketable Securities | 668,305 | 622,203 | 324,237 | 308,343 | 264,856 |
| Receivables | 113,762 | 90,975 | 112,099 | 153,196 | 88,391 |
| Inventories | 47,761 | 53,908 | 55,978 | 58,554 | 58,343 |
| TOTAL | $988,689 | $926,287 | $1,017,299 | $999,750 | $941,719 |
| Non-Current Assets | |||||
| PPE Net | 8,513 | 8,794 | 9,588 | 10,132 | 10,366 |
| Other Non-Current Assets | 165,046 | 169,348 | 158,533 | 15,981 | 14,497 |
| TOTAL | $173,559 | $178,142 | $168,121 | $26,113 | $24,863 |
| Total Assets | $1,162,248 | $1,104,429 | $1,185,420 | $1,025,863 | $966,582 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 89,546 | 89,419 | 89,251 | 89,167 | 89,042 |
| Accounts payable and accrued liabilities | 1,266 | 1,541 | 3,322 | 4,563 | 535 |
| Accrued Expenses | 19,133 | 24,441 | 18,335 | 19,274 | 16,098 |
| TOTAL | $111,691 | $117,147 | $113,153 | $114,251 | $107,421 |
| Non-Current Liabilities | |||||
| Long Term Debt | 788,099 | 787,255 | 786,454 | 785,571 | 784,731 |
| Deferred Revenues | 1,746 | 1,746 | 2,245 | 1,247 | 1,746 |
| Other Non-Current Liabilities | 171 | 544 | 1,609 | 2,267 | 2,809 |
| TOTAL | $790,301 | $790,329 | $790,593 | $791,864 | $791,566 |
| Total Liabilities | $901,992 | $907,476 | $903,746 | $906,115 | $898,987 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 137,950 | 137,704 | 140,787 | 142,335 | 142,386 |
| Common Shares | 138 | 138 | 141 | 142 | 143 |
| Retained earnings | 1,196 | -58,912 | -125,682 | -342,267 | -433,725 |
| Other shareholders' equity | -2,791 | -620 | -14 | -24 | -9 |
| TOTAL | $260,256 | $196,953 | $281,674 | $119,748 | $67,595 |
| Total Liabilities And Equity | $1,162,248 | $1,104,429 | $1,185,420 | $1,025,863 | $966,582 |